Stage FocusSeries A, Series B+
GeographyEurope, US
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedtechSynthetic BiologyNeurotech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Pureos Bioventures invests in private companies developing next-generation biological drugs and drug formats for severe diseases. Its team is led by founding partners Dominik Escher, previously founder and CEO of ESBATech, which was acquired by Alcon (Novartis) for USD 589 million, and Klaus Breiner and Martin Münchbach, both venture investors since the late 1990s/early 2000s and formerly senior i...
Notable Investments
A
Acrivon TherapeuticsA
Araris BiotechC
Corlieve TherapeuticsI
ImCheck TherapeuticsC
CitryllA
AnaCardioA
Alentis TherapeuticsP
PulseSight TherapeuticsN
NovaGo TherapeuticsM
Mediar TherapeuticsV
Vico TherapeuticsA
Ariceum TherapeuticsSimilar Funds
NV
Navigare Ventures
Stockholm, Sweden
Pure DeepTechBiotechSemiconductorsAdvanced MaterialsSeedSeries A
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
Flagship Pioneering
Cambridge, United States
Pure DeepTechBiotechAgritechAIPre-SeedSeed